Numerous clinical trials evaluate medroxyprogesterone acetate across all developmental stages, spanning Early Phase 1 through Phase 4. These investigations address diverse indications—including female infertility, HIV prevention, renal allograft transplantation, periodontal diseases, and systemic sclerosis—and encompass completed, recruiting, active, and terminated protocols. A wide network of entities sponsors these efforts, ranging from academic and clinical institutions to pharmaceutical companies.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT04877288 | RECRUITING | Renal Allograft Recipients |
Bristol-Myers Squibb |
2021-07-21 | PHASE3 |
| NCT07462663 | NOT_YET_RECRUITING | Endometrial Cancer; Endometrial Cancer Stage I; Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I; Atypical Endometrial Hyperplasia; Endometrial Intraepithelial Neoplasia; Obesity & Overweight; BMI>40; Obesity; Obesity Grade III |
Hospital Universitari de Bellvitge |
2027-01 | PHASE4 |
| NCT07488949 | RECRUITING | Chronic Endometritis |
Fang Wang |
2024-04-09 | |
| NCT06942156 | NOT_YET_RECRUITING | Heart Transplant |
Chong Kun Dang Pharmaceutical |
2025-08-14 | PHASE4 |
| NCT05255653 | RECRUITING | Endometrial Cancer |
Leiden University Medical Center |
2021-11-11 | PHASE2; PHASE3 |
| NCT06549855 | RECRUITING | Endometrial Cancer; Endometrioid Carcinoma; Mismatch Repair Deficiency |
Peking University People's Hospital |
2024-09-02 | |
| NCT06868290 | ACTIVE_NOT_RECRUITING | ANCA Associated Vasculitis (AAV) |
Novartis Pharmaceuticals |
2025-03-13 | PHASE2 |
| NCT06665256 | ACTIVE_NOT_RECRUITING | Idiopathic Inflammatory Myopathies |
Novartis Pharmaceuticals |
2024-12-17 | PHASE2 |
| NCT07611214 | RECRUITING | Lupus Nephritis |
Aurinia Pharmaceuticals Inc. |
2026-04-22 | PHASE4 |
| NCT07359859 | RECRUITING | Hematologic Malignancies |
Memorial Sloan Kettering Cancer Center |
2026-01-20 | PHASE2 |
| NCT06665997 | RECRUITING | Sickle Cell Disease (SCD); Vaso-Occlusive Pain Episode in Sickle Cell Disease |
University of Pennsylvania |
2025-06-26 | PHASE4 |
| NCT06468215 | RECRUITING | Carcinoma, Endometrioid; Fertility Preservation |
Peking University People's Hospital |
2024-06-21 | |
| NCT07508787 | RECRUITING | Renal Transplant Failure and Rejection |
Nefro Avillion Clinical Development, LLC |
2026-06-29 | PHASE2 |
| NCT06973668 | RECRUITING | AML |
M.D. Anderson Cancer Center |
2025-07-22 | PHASE2 |
| NCT07570433 | NOT_YET_RECRUITING | CMV Infection |
Oriol Manuel |
2026-04 | PHASE4 |
| NCT07319429 | RECRUITING | Endometrial Cancer; Fertility |
Fudan University |
2026-01-25 | PHASE2; PHASE3 |
| NCT06297096 | RECRUITING | Systemic Sclerosis; Interstitial Lung Disease |
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland |
2025-07-01 | PHASE3 |
| NCT06979596 | RECRUITING | Malignant Neoplasm |
Merck Sharp & Dohme LLC |
2025-08-11 | PHASE2 |
| NCT04888741 | RECRUITING | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; Non Hodgkin Lymphoma; Hodgkin Lymphoma; Multiple Myeloma; Chronic Myelogenous Leukemia; Myelofibrosis |
University of Birmingham |
2021-02-22 | PHASE2 |
| NCT06258915 | NOT_YET_RECRUITING | Non Infectious Uveitis |
Assistance Publique - Hôpitaux de Paris |
2024-03-01 | PHASE3 |
| NCT05044962 | RECRUITING | HIV Infections; Contraception; Drug-drug Interaction |
University of Alabama at Birmingham |
2021-11-26 | |
| NCT05247268 | RECRUITING | Endometrial Neoplasm Malignant Stage I |
Fudan University |
2022-03-11 | PHASE2 |
| NCT05060991 | ACTIVE_NOT_RECRUITING | COVID-19; Immunosuppression; Vaccine Response Impaired |
University of California, Davis |
2021-09-24 | PHASE4 |
| NCT04997499 | ACTIVE_NOT_RECRUITING | Medication Compliance; Contraception; Self-Evaluation |
Tufts Medical Center |
2021-09-29 | |
| NCT05365672 | RECRUITING | Kidney Transplantation |
TolerogenixX GmbH |
2022-05-04 | PHASE2 |
| NCT05760144 | RECRUITING | Contraception |
Oregon Health and Science University |
2023-07-01 | EARLY_PHASE1 |
| NCT07124195 | NOT_YET_RECRUITING | Malignant Solid Tumors; Moderate to High Emetogenic Chemotherapy (MEC/HEC) Drugs |
The First Affiliated Hospital of Xinxiang Medical College |
2025-08-10 | PHASE3 |
| NCT05193565 | ACTIVE_NOT_RECRUITING | Kidney Transplantation |
Chong Kun Dang Pharmaceutical |
2021-11-19 | PHASE4 |
| NCT06904274 | WITHDRAWN | Endometrial Hyperplasia |
Bayer |
2025-11-24 | PHASE3 |
| NCT05669001 | COMPLETED | Renal Transplantation |
ITB-Med LLC |
2023-12-28 | PHASE2 |
| NCT04547049 | ACTIVE_NOT_RECRUITING | Leukemia; MDS |
First Affiliated Hospital of Zhejiang University |
2020-09-01 | PHASE3 |
| NCT03292861 | ENROLLING_BY_INVITATION | Heart Transplantation |
Cedars-Sinai Medical Center |
2018-09-13 | PHASE2 |
| NCT07291648 | COMPLETED | Tinnitus |
University of Nottingham |
2025-09-01 | |
| NCT05675787 | UNKNOWN | Atypical Endometrial Hyperplasia; Endometrial Carcinoma Stage I |
Peking University People's Hospital |
2023-01-06 | PHASE2 |
| NCT06816901 | COMPLETED | Postpartum Contraception; Depot Medroxyprogesterone Acetate; Lactation; DMPA |
University of California, San Diego |
2025-03-26 | PHASE4 |
| NCT02416388 | RECRUITING | Acute Myeloid Leukemia (AML) |
University Hospital, Angers |
2015-01 | PHASE2; PHASE3 |
| NCT04893798 | COMPLETED | Healthy |
Pfizer |
2021-09-16 | PHASE1 |
| NCT06637189 | NOT_YET_RECRUITING | Stimulation in the Ovary; Embryo; Oocyte; Oocyte Retrieval; Fertilization in Vitro; Blastocyst; PGT-A |
Ginefiv |
2024-10-15 | PHASE4 |
| NCT03246906 | TERMINATED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Aggressive Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Diffuse Large B-Cell Lymphoma; Mantle Cell Lymphoma; Myelodysplastic Syndrome; Myelodysplastic/Myeloproliferative Neoplasm; Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Hematologic and Lymphocytic Disorder; Blastic Plasmacytoid Dendritic Cell Neoplasm |
Fred Hutchinson Cancer Center |
2017-09-11 | PHASE2 |
| NCT03942887 | UNKNOWN | ANCA Associated Vasculitis |
Leiden University Medical Center |
2019-05-03 | PHASE3 |
| NCT04414735 | UNKNOWN | Kidney Transplant Rejection |
Fundacion Clinic per a la Recerca Biomédica |
2022-08-17 | |
| NCT04997811 | UNKNOWN | Myelodysplastic Syndromes (MDS) |
Prof. Janet Dunn |
2021-12-21 | PHASE2 |
| NCT07470632 | COMPLETED | Exam Anxiety |
Near East University, Turkey |
2025-01-05 | |
| NCT06365437 | TERMINATED | Kidney Transplantation |
ITB-Med LLC |
2021-06-06 | PHASE2 |
| NCT01428973 | UNKNOWN | Graft-Versus-Host Disease; Hematological Malignancies |
University of Liege |
2011-09 | PHASE2 |
| NCT05767086 | COMPLETED | Infertility |
Bezmialem Vakif University |
2023-03-15 | |
| NCT06304220 | UNKNOWN | Infertility, Female; Fertility Disorders |
NextFertility |
2024-07 | |
| NCT05178563 | Not yet recruiting | Inflammation|Periodontal Diseases |
University College London |
2024-09-01 | Not Applicable |
| NCT06145438 | COMPLETED | Endometriosis Ovary |
Universitas Diponegoro |
2023-09-04 | PHASE3 |
| NCT06067217 | UNKNOWN | Abnormal Uterine Bleeding; Tranexamic Acid; Estrogen; Depot Medroxyprogesterone Acetate |
Department of Medical Services Ministry of Public Health of Thailand |
2023-09-30 | |
| NCT06584773 | UNKNOWN | Disorder Related to Renal Transplantation |
University of Sao Paulo General Hospital |
2015-06 | PHASE4 |
| NCT05565573 | UNKNOWN | Fertility Sparing |
Hua Li |
2022-11-01 | PHASE2; PHASE3 |
| NCT06297096 | Not yet recruiting | Systemic Sclerosis|Interstitial Lung Disease |
National Institute of Geriatrics Rheumatology and Rehabilitation Poland|Medical Research Agency Poland |
2024-04-01 | Phase 3 |
| NCT06193135 | Not yet recruiting | Infertility Female|Reproductive Sterility |
Instituto Valenciano de Infertilidad IVI VALENCIA |
2024-03-01 | Not Applicable |
| NCT04773392 | TERMINATED | Kidney Transplantation; Kidney Transplant Rejection |
University of Southern California |
2021-11-23 | PHASE4 |
| NCT05166967 | COMPLETED | Haploidentical Hematopoietic Stem Cell Transplantation |
Chinese PLA General Hospital |
2022-01-01 | PHASE3 |
| NCT04669678 | COMPLETED | HIV Infections; Contraception; Drug-drug Interaction |
University of Alabama at Birmingham |
2021-11-17 | PHASE4 |
| NCT05158608 | UNKNOWN | Graft Versus Host Disease; Hematologic Malignancy; Cyclophosphamide Adverse Reaction |
National Research Center for Hematology, Russia |
2022-01-01 | PHASE3 |
| NCT04726553 | UNKNOWN | Systemic Lupus Erythematosus (SLE) |
Oklahoma Medical Research Foundation |
2021-01-20 | EARLY_PHASE1 |
| NCT04927390 | UNKNOWN | Systemic Sclerosis; Limited Cutaneous Systemic Sclerosis |
University College, London |
2021-12-08 | PHASE2 |
| NCT05726903 | COMPLETED | Gender Dysphoria, Adolescent |
University of Colorado, Denver |
2022-12-06 | PHASE4 |
| NCT04311632 | COMPLETED | Kidney Transplantation |
ITB-Med LLC |
2021-05-26 | PHASE2 |
| NCT05505435 | COMPLETED | Contraception |
Northwestern University |
2022-08-01 | PHASE4 |
| NCT03899103 | COMPLETED | Steroid-Dependent Nephrotic Syndrome |
Nilratan Sircar Medical College |
2019-05-15 | PHASE3 |
| NCT04910711 | UNKNOWN | Human Immunodeficiency Virus; Contraception; ART |
Botswana Harvard AIDS Institute Partnership |
2021-10-21 | PHASE4 |
| NCT04225988 | COMPLETED | Kidney Transplant Rejection |
Cedars-Sinai Medical Center |
2020-01-09 | PHASE4 |
| NCT05973253 | COMPLETED | Photorefractive Keratectomy |
Isfahan University of Medical Sciences |
2023-04-21 | PHASE2; PHASE3 |
| NCT03386539 | COMPLETED | Pediatric Heart Transplantation; Immunosuppression; Chronic Kidney Diseases; Cardiac Allograft Vasculopathy; Heart Transplant Failure and Rejection; Post-transplant Lymphoproliferative Disorder; Heart Transplant Infection |
Boston Children's Hospital |
2018-01-29 | PHASE3 |
| NCT04280601 | COMPLETED | ANCA-associated Vasculitis; Granulomatosis With Polyangiitis; Microscopic Polyangiitis; Eosinophilic Granulomatosis With Polyangiitis |
Christian Pagnoux |
2020-08-01 | |
| NCT04989348 | COMPLETED | IVF |
Shanghai First Maternity and Infant Hospital |
2021-08-04 | |
| NCT04669210 | COMPLETED | Graft-versus-host-disease; Stem Cell Transplant Complications; Acute Myeloid Leukemia; Acute Lymphoid Leukemia |
St. Petersburg State Pavlov Medical University |
2020-11-03 | PHASE2 |
| NCT04444843 | UNKNOWN | Kidney Transplant Recipients |
First Affiliated Hospital Xi'an Jiaotong University |
2021-01-22 | PHASE4 |
| NCT04814927 | COMPLETED | Mucosal Inflammation; Contraceptive; Complications, Intrauterine |
Eastern Virginia Medical School |
2021-03-01 | PHASE4 |
| NCT05491343 | UNKNOWN | Arteriovenous Malformations |
HaEmek Medical Center, Israel |
2022-08 | PHASE4 |
| NCT04414761 | COMPLETED | IVF; GnRH Antagonist; PPOS |
ShangHai Ji Ai Genetics & IVF Institute |
2020-06-04 | PHASE3 |
| NCT04903054 | WITHDRAWN | Kidney Transplantation; Renal Transplant Recipients |
National Institute of Allergy and Infectious Diseases (NIAID) |
2022-01-10 | PHASE2 |
| NCT03959241 | COMPLETED | Acute Leukemia; Chronic Myelogenous Leukemia (CML); Myelodysplasia; Lymphoma |
Medical College of Wisconsin |
2019-06-25 | PHASE3 |
| NCT02426502 | UNKNOWN | End-Stage Renal Disease |
University of British Columbia |
2016-04 | |
| NCT04778618 | UNKNOWN | Haploidentical Hematopoietic Stem Cell Transplantation |
Chinese PLA General Hospital |
2020-12-01 | PHASE2 |
| NCT03794492 | COMPLETED | Kidney Transplant |
Chong Kun Dang Pharmaceutical |
2018-03-31 | PHASE4 |
| NCT04682353 | COMPLETED | Contraception |
Teva Branded Pharmaceutical Products R&D, Inc. |
2020-12-14 | PHASE1 |
| NCT03675139 | COMPLETED | Endometrial Hyperplasia Without Atypia |
Xiaojun Chen |
2019-02-26 | PHASE3 |
| NCT04710017 | COMPLETED | Uterine Bleeding |
Assiut University |
2021-02-01 | |
| NCT04654741 | UNKNOWN | IVF; Infertility |
Casa di Cura Privata Villa Mafalda |
2020-09-01 | PHASE4 |
| NCT04021420 | UNKNOWN | Melanoma; Metastatic Melanoma |
Assistance Publique - Hôpitaux de Paris |
2019-10-24 | PHASE1; PHASE2 |
| NCT03591380 | TERMINATED | Kidney Transplantation |
University of Wisconsin, Madison |
2019-05-14 | PHASE2 |
| NCT02617108 | UNKNOWN | Uterine Septum |
Fu Xing Hospital, Capital Medical University |
2019-12 | |
| NCT04424602 | COMPLETED | Lupus Nephritis |
Al-Azhar University |
2021-04-05 | PHASE4 |
| NCT01822288 | COMPLETED | Menopausal Syndromes |
Far Eastern Memorial Hospital |
2012-11-16 | PHASE4 |
| NCT00423514 | COMPLETED | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes |
Memorial Sloan Kettering Cancer Center |
2006-11-20 | PHASE1; PHASE2 |
| NCT02449161 | TERMINATED | Menorrhagia |
Guy Waddell |
2015-08 | PHASE3 |
| NCT03468478 | COMPLETED | Kidney Transplant Infection |
Hospital do Rim e Hipertensão |
2017-06-18 | PHASE4 |
| NCT03671473 | WITHDRAWN | Carpal Tunnel Syndrome |
Tri-Service General Hospital (TSGH) |
2019-01-01 | |
| NCT03395756 | COMPLETED | Emergency Contraception; Contraception |
University of Southern California |
2018-08-31 | EARLY_PHASE1 |
| NCT02943655 | COMPLETED | Improve Quality of Life; Heavy Menstrual Bleeding |
Assiut University |
2017-11-01 | PHASE3 |
| NCT03712345 | TERMINATED | Granulomatosis With Polyangiitis (GPA); Microscopic Polyangiitis (MPA) |
InflaRx GmbH |
2018-10-15 | PHASE2 |
| NCT01935128 | COMPLETED | Renal Transplant |
University of Toledo Health Science Campus |
2013-07-03 | PHASE4 |
| NCT01265017 | WITHDRAWN | Type 1 Diabetes |
Sansum Diabetes Research Institute |
2012-07 | PHASE1 |
| NCT02432339 | UNKNOWN | Psychological Stress; Hypertension, Renal |
Augusta University |
2014-04-22 | PHASE1; PHASE2 |
| NCT02357368 | COMPLETED | HIV; Contraception |
Lisa Haddad |
2015-02 | PHASE4 |
| NCT02974686 | TERMINATED | Kidney Transplant Rejection; Gastrointestinal Disorder, Functional |
Washington University School of Medicine |
2016-11 | PHASE4 |
| NCT01936519 | COMPLETED | Immunosuppression; Renal Failure |
Milton S. Hershey Medical Center |
2013-12-16 | |
| NCT03300960 | COMPLETED | Infertility |
Instituto Valenciano de Infertilidad, IVI VALENCIA |
2017-10-20 | PHASE3 |
| NCT03644225 | COMPLETED | Systemic Sclerosis |
Oliver Distler |
2018-06-11 | |
| NCT02991768 | TERMINATED | Diarrhea |
University of Kansas Medical Center |
2017-01-27 | PHASE2 |
| NCT02435901 | COMPLETED | Sickle Cell Disease; Beta Thalassemia-Major |
Northwell Health |
2008-12 | PHASE1; PHASE2 |
| NCT01265537 | COMPLETED | Acute Graft Rejection; Diabetes |
University of British Columbia |
2011-06-24 | |
| NCT03911583 | UNKNOWN | Overweight; Obesity |
Universidad de Córdoba |
2016-01-01 | |
| NCT02817464 | COMPLETED | Pregnancy; Contraception |
Teva Branded Pharmaceutical Products R&D, Inc. |
2016-10-26 | PHASE1 |
| NCT02383589 | COMPLETED | Pemphigus Vulgaris |
Hoffmann-La Roche |
2015-05-26 | PHASE3 |
| NCT02550067 | COMPLETED | HIV; Contraception |
FHI 360 |
2015-12-14 | |
| NCT02456584 | COMPLETED | Contraception |
FHI 360 |
2015-09 | PHASE1 |
| NCT02433522 | COMPLETED | ANCA-associated Vasculitides |
Assistance Publique - Hôpitaux de Paris |
2015-03-31 | PHASE3 |
| NCT01541176 | COMPLETED | Renal Transplant |
Nantes University Hospital |
2012-04 | PHASE4 |
| NCT03255941 | COMPLETED | Contraception |
FHI 360 |
2018-03-19 | EARLY_PHASE1 |
| NCT02103764 | UNKNOWN | Dysfunctional Uterine Bleeding |
Mahidol University |
2013-08 | PHASE3 |
| NCT03018249 | COMPLETED | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma |
National Cancer Institute (NCI) |
2017-10-11 | EARLY_PHASE1 |
| NCT03197961 | COMPLETED | HIV/AIDS; Contraception |
Sharon Achilles |
2017-11-17 | EARLY_PHASE1 |
| NCT02042690 | COMPLETED | Acute Lymphoblastic Leukemia |
Peking University |
2014-07 | PHASE3 |
| NCT02228681 | COMPLETED | Advanced, Persistent, or Recurrent Endometrial Cancer |
GOG Foundation |
2015-05-21 | PHASE2 |
| NCT01824693 | COMPLETED | Juvenile Myelomonocytic Leukemia |
Children's Oncology Group |
2013-06-24 | PHASE2 |
| NCT03309176 | COMPLETED | Ovulation Disorder |
Radboud University Medical Center |
2016-06-21 | PHASE4 |
| NCT01878786 | TERMINATED | Delayed Graft Function |
Matthew Cooper |
2013-06 | PHASE2; PHASE3 |
| NCT02208037 | COMPLETED | Acute Leukemia; Chronic Myelogenous Leukemia; Myelodysplasia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Hodgkin's Lymphoma |
National Heart, Lung, and Blood Institute (NHLBI) |
2014-08 | PHASE2 |
| NCT02411084 | TERMINATED | Graft vs Host Disease |
Adienne SA |
2016-02 | PHASE3 |
| NCT02896205 | COMPLETED | Systemic Sclerosis; Scleroderma; Interstitial Lung Disease |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2016-10 | PHASE3 |
| NCT02412436 | COMPLETED | HIV-1 Infection; Tuberculosis |
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections |
2015-11-03 | PHASE2 |
| NCT02122198 | COMPLETED | Cognitive Impairment; Executive Dysfunction; Endothelial Dysfunction; Cardiovascular Disease |
University of Colorado, Denver |
2014-09-08 | |
| NCT03443089 | COMPLETED | Contraception |
Galeno Desenvolvimento de Pesquisas Clínicas |
2017-03-31 | PHASE1 |
| NCT02509767 | COMPLETED | Contraception |
Planned Parenthood Federation of America |
2015-08 | PHASE4 |
| NCT02103660 | COMPLETED | HIV; Contraception |
Centers for Disease Control and Prevention |
2014-04-08 | PHASE4 |
| NCT01580865 | COMPLETED | Lupus Nephritis |
Ramathibodi Hospital |
2012-05 | |
| NCT01463202 | COMPLETED | Contraception; Postpartum Depression; Lactation |
Beatrice Chen |
2011-11 | PHASE4 |
| NCT01950819 | COMPLETED | End Stage Renal Disease (ESRD); Chronic Kidney Disease (CKD); Hemodialysis; Renal Replacement Therapy; Renal Transplantation |
Novartis Pharmaceuticals |
2013-12-03 | PHASE4 |
| NCT02083991 | COMPLETED | Diabetes Mellitus |
Vastra Gotaland Region |
2013-01 | PHASE4 |
| NCT02152345 | COMPLETED | Implant or Graft; Rejection |
Columbia University |
2014-06 | PHASE4 |
| NCT02390362 | TERMINATED | Frequent Relapsing Nephrotic Syndrome; Steroid Dependent Nephrotic Syndrome |
Nationwide Children's Hospital |
2015-01 | PHASE3 |
| NCT02272647 | COMPLETED | Healthy |
Mayo Clinic |
2014-12 | PHASE1 |
| NCT01544491 | COMPLETED | Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant |
Novartis Pharmaceuticals |
2012-08-17 | PHASE3 |
| NCT02561767 | UNKNOWN | Kidney Transplantation; Acute Kidney Tubular Necrosis |
First Affiliated Hospital, Sun Yat-Sen University |
2015-10 | PHASE1; PHASE2 |
| NCT01875224 | UNKNOWN | New Onset Diabetes After Transplant; Kidney Transplantation |
University of Arizona |
2013-08 | PHASE4 |
| NCT01707849 | COMPLETED | Hepatitis C Recurrence After Liver Transplant |
Hospital Vall d'Hebron |
2012-10 | PHASE3 |
| NCT00494741 | COMPLETED | Kidney Transplant |
Mario Negri Institute for Pharmacological Research |
2007-05 | PHASE4 |
| NCT01860183 | COMPLETED | Kidney Transplantation; Kidney Failure |
Clinical Hospital Merkur |
2013-05 | PHASE4 |
| NCT01299116 | COMPLETED | Contraception |
FHI 360 |
2011-12 | PHASE4 |
| NCT02534688 | COMPLETED | Endometriosis |
King Chulalongkorn Memorial Hospital |
2015-06 | PHASE4 |
| NCT02894151 | COMPLETED | Clinically Diagnosed Endometriotic Patient Was Defined as a Woman Who Has Pelvic Pain and at Least One Evidence of PV or TVS |
Chulalongkorn University |
2015-04 | PHASE2 |
| NCT02335203 | UNKNOWN | Grade 1 Endometrial Endometrioid Adenocarcinoma; Grade 2 Endometrial Endometrioid Adenocarcinoma; Complex Atypical Endometrial Hyperplasia |
Women and Infants Hospital of Rhode Island |
2015-02 | PHASE2 |
| NCT01895049 | COMPLETED | Kidney Transplantation; Cytomegalovirus |
Helio Tedesco Silva Junior |
2013-08 | PHASE4 |
| NCT01766375 | UNKNOWN | Acute Myeloid Leukemia |
Guangxi Medical University |
2012-08 | PHASE3 |
| NCT01067300 | UNKNOWN | Leukemia |
Assistance Publique Hopitaux De Marseille |
2010-02 | PHASE3 |
| NCT01410448 | COMPLETED | Kidney Transplantation |
Novartis Pharmaceuticals |
2011-11 | PHASE3 |
| NCT02036554 | UNKNOWN | Kidney; Complications, Allograft |
Seoul St. Mary's Hospital |
2013-03 | PHASE4 |
| NCT02058875 | WITHDRAWN | Cardiovascular Disease; Cardiovascular Outcomes; Kidney Transplant Recipients; Kidney Transplantation |
University of Saskatchewan |
2014-02 | PHASE4 |
| NCT00933231 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2009-08-17 | PHASE3 |
| NCT00997893 | COMPLETED | Menopause; Hot Flashes |
University of Illinois at Chicago |
2009-12 | PHASE2 |
| NCT02340013 | COMPLETED | Infertility |
Samuel Lunenfeld Research Institute, Mount Sinai Hospital |
2013-07 | PHASE4 |
| NCT01461824 | COMPLETED | Weight Gain; Disorder of Bone Density and Structure, Unspecified; Uterine Bleeding |
Nationwide Children's Hospital |
2011-09 | PHASE3 |
| NCT02872818 | COMPLETED | Apoptotic Signal Pathways in Endometrial Hyperplasia |
Kayseri Education and Research Hospital |
2014-10 | PHASE4 |
| NCT02123108 | COMPLETED | Liver Transplantation |
University of California, Los Angeles |
2011-01 | PHASE4 |
| NCT01594879 | UNKNOWN | Endometrial Cancer |
Korean Gynecologic Oncology Group |
2012-01 | PHASE2 |
| NCT00103792 | COMPLETED | Wegener's Granulomatosis; Vasculitis |
University Medical Center Groningen |
2004-12 | PHASE3 |
| NCT01134952 | COMPLETED | Hepatitis C |
London Health Sciences Centre |
2010-06 | PHASE4 |
| NCT01244659 | WITHDRAWN | Renal Transplant |
EMS |
2014-05 | PHASE3 |
| NCT01197040 | COMPLETED | Nephrotic Syndrome |
Assistance Publique - Hôpitaux de Paris |
2009-10 | PHASE3 |
| NCT00371319 | COMPLETED | Lupus Nephritis |
Tuen Mun Hospital |
2005-09 | PHASE4 |
| NCT01776203 | TERMINATED | Dysfunctional Uterine Bleeding |
Kaiser Permanente |
2012-01 | PHASE4 |
| NCT01766518 | UNKNOWN | Evidence of Liver Transplantation |
Chong Kun Dang Pharmaceutical |
2009-11 | PHASE4 |
| NCT00412360 | COMPLETED | Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome; Natural Killer Cell Lymphoblastic Leukemia/Lymphoma |
Medical College of Wisconsin |
2006-12 | PHASE3 |
| NCT01421368 | COMPLETED | HIV Prevention |
CONRAD |
2012-03 | PHASE1 |
| NCT01169701 | COMPLETED | Renal Transplant |
Novartis Pharmaceuticals |
2010-08 | PHASE4 |
| NCT00075478 | COMPLETED | Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Aggressive Non-Hodgkin Lymphoma; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Diffuse Large B-Cell Lymphoma; Hematopoietic and Lymphoid Cell Neoplasm; Indolent Non-Hodgkin Lymphoma; Mantle Cell Lymphoma; Myelodysplastic/Myeloproliferative Neoplasm; Plasma Cell Myeloma; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Waldenstrom Macroglobulinemia |
Fred Hutchinson Cancer Center |
2003-10 | PHASE3 |
| NCT01410162 | COMPLETED | Renal Transplant; Kidney Pancreas Transplant |
Norman Muirhead |
2010-12 | PHASE4 |
| NCT01074892 | COMPLETED | Endometrial Hyperplasia |
University Hospital of North Norway |
2005-05 | PHASE4 |
| NCT01630252 | COMPLETED | Endometriosis |
PregLem SA |
2012-06 | PHASE2 |
| NCT00693446 | UNKNOWN | Pancreas Transplantation; Kidney Transplantation |
Nantes University Hospital |
2004-04 | PHASE4 |
| NCT01187953 | COMPLETED | Renal Failure |
Veloxis Pharmaceuticals |
2010-09 | PHASE3 |
| NCT01791413 | COMPLETED | Endometriosis |
Mahidol University |
2012-03 | PHASE1; PHASE2 |
| NCT00332839 | TERMINATED | Renal Transplantation |
Novartis Pharmaceuticals |
2005-11 | PHASE4 |
| NCT00956293 | TERMINATED | Renal Transplantation |
Novartis Pharmaceuticals |
2009-07 | PHASE4 |
| NCT00743574 | COMPLETED | Polycystic Ovarian Syndrome; Vitamin D Deficiency |
Yale University |
2008-08 | |
| NCT01296152 | COMPLETED | HIV-1 Infection |
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections |
2011-05 | PHASE2 |
| NCT01276834 | TERMINATED | Renal Transplantation |
Dianet Dialysis Centers |
2010-09 | PHASE4 |
| NCT01399242 | UNKNOWN | Disorder Related to Renal Transplantation |
Hospital Universitário São José |
2011-08 | PHASE4 |
| NCT01230502 | TERMINATED | Liver Transplant |
University of Wisconsin, Madison |
2011-11 | |
| NCT00322101 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Acute Myeloid Leukemia/Transient Myeloproliferative Disorder; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Acute Myeloid Leukemia in Remission; Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Myelodysplastic Syndrome With Isolated Del(5q); Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
2006-01 | PHASE3 |
| NCT00490555 | COMPLETED | Healthy |
University of Washington |
2009-01 | PHASE2; PHASE3 |
| NCT00817687 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2009-01 | PHASE4 |
| NCT01109979 | COMPLETED | Cardiovascular Diseases |
Brigham and Women's Hospital |
2009-12 | PHASE4 |
| NCT01288131 | TERMINATED | Anti-r-HuEpo Associated PRCA Subjects |
Chulalongkorn University |
2009-01 | PHASE3 |
| NCT00370019 | WITHDRAWN | Premature Ovarian Failure |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
2006-08-25 | PHASE2 |
| NCT01191203 | COMPLETED | HIV |
Emory University |
2010-07 | |
| NCT00577122 | COMPLETED | Estrogen Receptor-negative Breast Cancer; Progesterone Receptor-negative Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer |
Indiana University |
2007-07 | PHASE2 |
| NCT01143207 | COMPLETED | Contraception |
FHI 360 |
2010-05 | |
| NCT00737659 | UNKNOWN | Renal Transplant |
Rabin Medical Center |
2008-08 | PHASE4 |
| NCT00204022 | COMPLETED | Lupus Nephritis |
Frédéric A. Houssiau, MD, PhD |
2001-02 | PHASE3 |
| NCT00717314 | COMPLETED | Liver Transplantation |
Hoffmann-La Roche |
2008-05 | PHASE4 |
| NCT00604357 | COMPLETED | End Stage Liver Disease; Impaired Renal Function |
University of Regensburg |
2008-12 | PHASE3 |
| NCT00300274 | COMPLETED | Graft Rejection |
Novartis Pharmaceuticals |
2006-01 | PHASE3 |
| NCT00307671 | COMPLETED | Vasculitis; Wegener's Granulomatosis; Microscopic Polyangiitis; Churg-Strauss Syndrome; Polyarteritis Nodosa |
Assistance Publique - Hôpitaux de Paris |
2005-07 | PHASE4 |
| NCT01231451 | WITHDRAWN | HIV Infection |
St Stephens Aids Trust |
2010-12 | PHASE1 |
| NCT00246129 | COMPLETED | Kidney Transplantation; Kidney Diseases; Kidney Failure |
EMagnusson |
2005-10 | PHASE4 |
| NCT01056042 | COMPLETED | Endometriosis |
Prince of Songkla University |
2007-06 | PHASE4 |
| NCT00808132 | COMPLETED | Menopause; Osteoporosis |
Pfizer |
2009-01 | PHASE3 |
| NCT00316810 | COMPLETED | Pancreas-Kidney Transplantation |
Dr. Claudia Bösmüller |
2006-04 | PHASE3 |
| NCT00739830 | COMPLETED | Endometrial Cancer |
Merck Sharp & Dohme LLC |
2008-08 | PHASE2 |
| NCT00758602 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2008-09 | PHASE4 |
| NCT01019369 | COMPLETED | Contraception |
Carolyn L. Westhoff |
2010-03 | |
| NCT01953796 | COMPLETED | Polycystic Ovary Syndrome |
Kufa University |
2010-05 | |
| NCT00311311 | TERMINATED | Atherosclerosis; Kidney Failure |
Pfizer |
2006-04 | PHASE3 |
| NCT01148420 | COMPLETED | Dysfunctional Uterine Bleeding |
Women's Health Care Clinic, Torrance, California |
2009-01 | PHASE4 |
| NCT00064025 | COMPLETED | Endometrial Adenocarcinoma; Endometrial Adenosquamous Carcinoma; Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation; Recurrent Uterine Corpus Carcinoma; Stage I Uterine Corpus Cancer; Stage II Uterine Corpus Cancer; Stage III Uterine Corpus Cancer; Stage IV Uterine Corpus Cancer |
Gynecologic Oncology Group |
2004-04 | PHASE2 |
| NCT01254799 | COMPLETED | Uterine Hemorrhage |
Omar Mamdouh Shaaban |
2008-01 | PHASE3 |
| NCT01033864 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2009-11 | PHASE4 |
| NCT01183247 | COMPLETED | Comparative Study; Immunosuppressive Agents |
University Hospital, Basel, Switzerland |
2008-07 | PHASE4 |
| NCT00928811 | TERMINATED | End Stage Renal Disease |
Drexel University College of Medicine |
2009-05 | PHASE2; PHASE3 |
| NCT00582738 | TERMINATED | Recurrent Hepatitis C |
Novartis Pharmaceuticals |
2007-12 | PHASE2 |
| NCT00040846 | COMPLETED | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Peripheral T-cell Lymphoma; Previously Treated Myelodysplastic Syndromes; Progressive Hairy Cell Leukemia, Initial Treatment; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2001-11 | PHASE2 |
| NCT00240994 | COMPLETED | Kidney Failure, Chronic; Kidney Transplantation; Immunosuppression |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-01 | PHASE2 |
| NCT00170846 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2005-02 | PHASE4 |
| NCT00720408 | COMPLETED | Liver Transplantation; Transplantation Immunology; Host vs Graft Reaction |
Astellas Pharma Inc |
2007-12 | PHASE3 |
| NCT00251004 | COMPLETED | Kidney Transplantation; Graft Rejection |
Novartis |
2005-10 | PHASE3 |
| NCT00351377 | COMPLETED | Autoimmune Disease |
Novartis Pharmaceuticals |
2006-06 | PHASE3 |
| NCT00299221 | COMPLETED | Immunosuppression |
Newark Beth Israel Medical Center |
2004-04 | PHASE4 |
| NCT00596947 | TERMINATED | Transplants and Implants |
University of Pennsylvania |
2005-10 | PHASE4 |
| NCT00113269 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2005-05 | PHASE4 |
| NCT00413920 | COMPLETED | Renal Transplantation |
Novartis |
2007-04 | PHASE3 |
| NCT02005562 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2006-05 | PHASE3 |
| NCT00481819 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2007-07 | PHASE3 |
| NCT00653159 | COMPLETED | Contraception |
University of Chicago |
2007-07 | PHASE4 |
| NCT00369278 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2006-06 | PHASE3 |
| NCT00437658 | COMPLETED | Endometriosis |
AbbVie |
2006-12-11 | PHASE2 |
| NCT00420342 | COMPLETED | Postmenopause; Hypertension; Pre-Hypertension |
Bayer |
2007-01 | PHASE2 |
| NCT00195273 | COMPLETED | Graft vs Host Disease; Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
2004-11 | PHASE3 |
| NCT00309218 | COMPLETED | Kidney Diseases |
Klinik für Kinder- und Jugendmedizin |
1999-03 | PHASE3 |
| NCT00360490 | COMPLETED | Menorrhagia |
Bayer |
2006-07 | PHASE3 |
| NCT01411592 | UNKNOWN | Restauration in Situ; Final Loss of Restauration; Debonded Restauration |
University of Kiel |
2006-10 | |
| NCT00668603 | COMPLETED | Postmenopausal Vasomotor Symptoms; Cardiovascular Disease |
University of Helsinki |
2005-08 | |
| NCT00321113 | COMPLETED | KIDNEY TRANSPLANTATION |
Astellas Pharma Inc |
2004-09 | PHASE3 |
| NCT00828542 | COMPLETED | Breastfeeding; Contraception |
University of Sao Paulo |
2007-07 | |
| NCT00337493 | COMPLETED | Kidney Transplantation |
Hoffmann-La Roche |
2005-12 | PHASE4 |
| NCT00191113 | COMPLETED | Turner Syndrome |
Eli Lilly and Company |
1989-02 | PHASE3 |
| NCT01011751 | COMPLETED | Adenocarcinoma, Prostate |
Takeda |
2004-04 | PHASE3 |
| NCT02554955 | COMPLETED | Heart Transplantation |
Hoffmann-La Roche |
2004-02 | PHASE4 |
| NCT00066157 | COMPLETED | Alzheimer Disease |
University of Wisconsin, Madison |
2001-09 | PHASE2; PHASE3 |
| NCT01283841 | COMPLETED | Fasting |
Dr. Reddy's Laboratories Limited |
2007-11 | PHASE1 |
| NCT01283867 | COMPLETED | FED |
Dr. Reddy's Laboratories Limited |
2007-11 | PHASE1 |
| NCT00543634 | COMPLETED | Postmenopause |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-10 | PHASE1 |
| NCT00275522 | COMPLETED | Kidney Transplant |
Mayo Clinic |
2005-12 | PHASE4 |
| NCT00033358 | COMPLETED | Endometrial Cancer |
National Cancer Institute (NCI) |
2002-02 | PHASE2 |
| NCT00775047 | COMPLETED | Contraception |
University of North Carolina, Chapel Hill |
2006-08 | |
| NCT00214266 | COMPLETED | Renal Transplantation |
University of Wisconsin, Madison |
2005-01 | PHASE2 |
| NCT00295594 | COMPLETED | Liver Transplantation |
Astellas Pharma Inc |
2005-03 | PHASE3 |
| NCT00105235 | COMPLETED | Liver Disease; Liver Transplantation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-06 | PHASE2 |
| NCT00083824 | COMPLETED | Cardiovascular Diseases; Coronary Disease; Heart Diseases; Coronary Arteriosclerosis |
Tufts University |
2004-03 | PHASE2; PHASE3 |
| NCT00905242 | COMPLETED | Kidney Transplantation |
East Carolina University |
2006-03 | PHASE4 |
| NCT00002920 | COMPLETED | Breast Cancer; Endometrial Cancer |
SWOG Cancer Research Network |
1997-03 | PHASE3 |
| NCT00189839 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2004-08 | PHASE3 |
| NCT00187941 | COMPLETED | Transplantation, Renal; Immunosuppression |
University of Florida |
2005-08 | EARLY_PHASE1 |
| NCT00141037 | COMPLETED | Kidney Diseases; Kidney Transplantation; Kidney Transplant; Renal Transplantation; Renal Transplant |
National Institute of Allergy and Infectious Diseases (NIAID) |
2004-03 | PHASE1; PHASE2 |
| NCT00284921 | TERMINATED | De Novo Kidney Transplant |
Novartis Pharmaceuticals |
2004-04 | PHASE3 |
| NCT00296309 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2004-10 | PHASE3 |
| NCT00912678 | COMPLETED | Kidney Transplantation |
University of Luebeck |
2002-03 | PHASE4 |
| NCT00296361 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2004-10 | PHASE3 |
| NCT00106639 | COMPLETED | Kidney Transplantation |
Pfizer |
2005-05 | PHASE2 |
| NCT00240955 | COMPLETED | Renal Transplantation |
Novartis |
2004-03 | PHASE4 |
| NCT00161447 | COMPLETED | Contraception |
University of Washington |
2004-05 | PHASE1; PHASE2 |
| NCT00003179 | TERMINATED | Endometrial Cancer |
Gynecologic Oncology Group |
1998-11 | PHASE2 |
| NCT00030914 | COMPLETED | Hot Flashes |
Alliance for Clinical Trials in Oncology |
2002-04 | PHASE3 |
| NCT00089947 | COMPLETED | Renal Transplantation; Graft Rejection |
Genzyme, a Sanofi Company |
2003-06 | PHASE2 |
| NCT00000897 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
||
| NCT00745108 | COMPLETED | Postmenopausal Women |
Organon and Co |
2001-10-01 | PHASE3 |
| NCT00238901 | COMPLETED | Liver Transplant |
Novartis |
2002-12 | PHASE3 |
| NCT00156650 | COMPLETED | Contraception |
University of Washington |
2004-12 | PHASE1; PHASE2 |
| NCT00154232 | COMPLETED | Renal Transplantation |
Novartis Pharmaceuticals |
2004-06 | PHASE4 |
| NCT00166244 | COMPLETED | De Novo Renal Transplant Recipient. |
Erasmus Medical Center |
2003-05 | PHASE4 |
| NCT00363116 | COMPLETED | Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients |
University of Cincinnati |
1999-04 | PHASE4 |
| NCT00693381 | COMPLETED | Kidney Transplantation |
Astellas Pharma Inc |
2003-02 | PHASE3 |
| NCT00830414 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2002-04 | PHASE1 |
| NCT00026286 | COMPLETED | Breast Cancer; Hot Flashes; Menopausal Symptoms |
Eastern Cooperative Oncology Group |
2000-11-28 | PHASE3 |
| NCT03097120 | COMPLETED | Heart Disease |
Wake Forest University Health Sciences |
1995-01 | PHASE3 |
| NCT01472315 | COMPLETED | Sleep Apnea |
Turku University Hospital |
2000-01 | PHASE2; PHASE3 |
| NCT00000605 | COMPLETED | Cardiovascular Diseases; Coronary Arteriosclerosis; Coronary Disease; Heart Diseases; Myocardial Ischemia; Postmenopause |
National Heart, Lung, and Blood Institute (NHLBI) |
1996-08 | PHASE3 |
| NCT00416429 | COMPLETED | Kidney Cancer |
Centre Leon Berard |
PHASE3 | |
| NCT00319566 | COMPLETED | Coronary Heart Disease |
University of California, San Francisco |
1992-07 | PHASE3 |
| NCT00004650 | COMPLETED | Osteoporosis |
National Institute of Dental and Craniofacial Research (NIDCR) |
1993-08 | PHASE3 |
| NCT00006324 | COMPLETED | HIV Infections |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
1999-12 | |
| NCT00044837 | TERMINATED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00291369 | COMPLETED | Metastatic Renal Cell Carcinoma |
Centre Leon Berard |
1999-12 | PHASE3 |
| NCT00729768 | WITHDRAWN | Kidney Transplantation |
Genentech, Inc. |
PHASE2; PHASE3 | |
| NCT00006133 | COMPLETED | Systemic Lupus Erythematosus |
National Center for Research Resources (NCRR) |
2000-06 | |
| NCT00169299 | UNKNOWN | Vasomotor Symptoms Associated With Menopause |
Kaiser Permanente |
2001-06 | PHASE4 |
| NCT00000466 | COMPLETED | Bone Diseases; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases; Hypercholesterolemia; Hypertension; Myocardial Ischemia; Osteoporosis; Thrombosis; Postmenopause |
National Heart, Lung, and Blood Institute (NHLBI) |
1987-09 | PHASE3 |
| NCT00401219 | COMPLETED | Estrogen Replacement Therapy |
Wyeth is now a wholly owned subsidiary of Pfizer |
2006-11 | PHASE1 |
| NCT00140543 | COMPLETED | Diabetes Mellitus, Type 1; Diabetic Nephropathy |
EUROSPK Study Group |
2002-02 | PHASE3 |
| NCT00332553 | COMPLETED | Vasomotor Symptoms; Endometrial Safety |
Eli Lilly and Company |
2002-02 | PHASE2 |
| NCT00261820 | COMPLETED | Graft Rejection; Kidney Failure; Kidney Transplantation |
Wyeth is now a wholly owned subsidiary of Pfizer |
PHASE4 | |
| NCT00000559 | COMPLETED | Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia; Postmenopause |
National Heart, Lung, and Blood Institute (NHLBI) |
1995-03 | PHASE3 |
| NCT00472927 | COMPLETED | Postmenopause |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-05 | PHASE1 |
| NCT00309270 | COMPLETED | Kidney Transplant |
Mario Negri Institute for Pharmacological Research |
2003-02 | PHASE2 |
| NCT00350480 | COMPLETED | Uterine Hemorrhage; Menorrhagia |
Kaiser Permanente |
2003-04 | |
| NCT00463450 | COMPLETED | Hormone Replacement Therapy |
Bayer |
2002-05 | PHASE3 |
| NCT00004567 | COMPLETED | Vasculitis; Wegener's Granulomatosis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2000-02 | PHASE2 |
| NCT00188955 | COMPLETED | Kidney Transplantation |
University of Manitoba |
2004-03 | PHASE4 |
| NCT00431119 | COMPLETED | Bullous Pemphigoid |
University Hospital Muenster |
1997-10 | PHASE2 |
| NCT00195988 | COMPLETED | Liver Transplantation |
Children's Memorial Health Institute, Poland |
2002-09 | PHASE4 |
| NCT00849238 | WITHDRAWN | Primary Liver Transplant |
University of Wisconsin, Madison |
||
| NCT00392093 | COMPLETED | Systemic Lupus Erythematosus |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
1997-11 | PHASE4 |
| NCT00381251 | COMPLETED | Postmenopausal Osteoporosis; Postmenopause |
Wyeth is now a wholly owned subsidiary of Pfizer |
2006-09 | PHASE1 |
| NCT00016601 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
2001-06 | |
| NCT00404794 | COMPLETED | Lupus Nephritis; Glomerulonephritis, Membranous |
Hospital Authority, Hong Kong |
2005-11 | PHASE3 |
(data from https://clinicaltrials.gov, updated on 2026-08-31)
Check the
Medroxyprogesterone Acetate (MPA)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Medroxyprogesterone Acetate (MPA) Solubility in DMSO
- Medroxyprogesterone Acetate (MPA) Stock Solution
- Medroxyprogesterone Acetate (MPA) Storage
- Medroxyprogesterone Acetate (MPA) Stability
- Medroxyprogesterone Acetate (MPA) Molecular Weight
- Medroxyprogesterone Acetate (MPA) SMILES
- Medroxyprogesterone Acetate (MPA) CAS Number
- Medroxyprogesterone Acetate (MPA) Chemical Structure (2D and 3D)
- Medroxyprogesterone Acetate (MPA) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.